A view shows a bottle and packaging of the immune drug Areima (camrelizumab) which has been developed for the treatment of nasopharyngeal and esophageal cancer and launched into production at the Petrovax plant, in Moscow region, Russia.
- Package: Russia Pharmaceutical Industry
- Categories: Science & Technology, Health
- Location: Moscow region, Russia
- Event date:
- Date published:
- Author: Mikhail Voskresenskiy
- Credit: Sputnik
- Source: Sputnik
- Original: Digital
- Media: JPEG, 4828x3153px, 5.7Mb
- Job-ID: 1c1d8e265b4f8c11